Insight Companies

Acne Treatment Market Key Developments and Leading Companies

Global Acne Treatment Market Growth, Key Players, and Future Outlook

The global acne treatment market is projected to expand from USD 9,615.6 million in 2022 to approximately USD 15,183.2 million by 2032, growing at a compound annual growth rate (CAGR) of 4.8% from 2023 to 2032. This growth is primarily driven by increasing clinical approvals and the launch of innovative products aimed at effectively treating acne.

Download statistics of this report @ https://www.towardshealthcare.com/download-statistics/5037

Dermatology Clinics Fueling Acne Treatment Market Growth

Dermatology clinics are playing a key role in driving the expansion of the acne treatment market. These specialized clinics offer comprehensive care for various skin issues, including acne. They provide a variety of treatment options, ranging from medications and therapies to cosmetic procedures, all tailored to address acne concerns.

In addition, dermatology clinics are investing in cutting-edge technologies and treatments to enhance the effectiveness of acne care. Many now utilize advanced tools like laser therapy and photodynamic therapy, which have been proven to reduce acne lesions and improve the overall appearance of the skin.

Recent Developments in the Acne Treatment Market Company Announcements

In May 2023, Bausch Health Companies Inc. and its dermatology subsidiary, Ortho Dermatologics, revealed that the U.S. Food and Drug Administration (FDA) accepted the New Drug Application (NDA) for IDP-126, a treatment currently under investigation. This marks a significant step forward for the company in advancing acne treatment options.

In July 2022, Glenmark Pharmaceuticals introduced MINYM, a topical Minocycline 4% Gel for the treatment of moderate to severe acne. Minocycline is a potent antibacterial gel with notable anti-inflammatory effects, and it is distinguished by having the lowest MIC90 compared to other topical antibacterial formulations.

In March 2022, Galderma launched Twyneo cream in the U.S., a topical treatment for acne vulgaris in patients aged 9 years or older. Twyneo is a fixed-dose combination of benzoyl peroxide (3%) and tretinoin (0.1%), offering a dual-action solution for acne care.

In November 2021, Sun Pharmaceutical Industries introduced Winlevi cream in the U.S. market for the treatment of acne vulgaris. Winlevi had previously received FDA approval in August 2020 and has since become a recognized acne treatment.

In June 2020, Thayer expanded its product offerings with a new acne-tailored skincare line, catering to the specific needs of individuals battling acne, providing targeted solutions for skincare and acne management.

Our Table of Content (TOC) covers key healthcare market segments, materials, technologies and trends—helping you navigate market shifts and make informed decisions: https://www.towardshealthcare.com/table-of-content/acne-treatment-market

Access exclusive insight now @ https://www.towardshealthcare.com/price/5037

We’ve prepared a service to support you. Please feel free to contact us at  sales@towardshealthcare.com

Web: https://www.towardshealthcare.com

Visit Dental Specifics: https://www.towardsdental.com

Get the latest insights on industry segmentation with our Annual Membership: Get a Subscription

For Latest Update Follow Us: https://www.linkedin.com/company/towards-healthcare

Elena Morales

Elena Morales is a healthcare industry expert working at Healthcare Web Wire Consulting Firm, a subsidiary of Towards Healthcare. With her excellent knowledge of the field, Elena helps clients optimize their operations and navigate healthcare regulations. She's dedicated to staying updated on industry trends to make a positive impact on patient care. Elena is known for her professionalism and commitment to excellence, making her a valuable asset to any team.

Recent Posts

Canadian Digital Health Market Sees Steady Growth in 2025

The global digital health market is witnessing a steady rise  and much of it is driven by the increasing number… Read More

6 hours ago

North America Takes the Lead in Healthcare CRO Market

In 2025, North America emerged as the clear frontrunner in the healthcare Contract Research Organization (CRO) market  and it’s easy… Read More

6 hours ago

Virocell and Avencell Team Up to Advance Breakthrough CAR-T Therapies

Powering the Future of Cell and Gene Therapy Virocell Biologics, a leading name in vector manufacturing for cell and gene… Read More

6 hours ago

Pahr Therapeutics Secures $14M to Advance New Treatments for Pulmonary Arterial Hypertension

A Big Leap Forward in PAH Care Pahr Therapeutics Inc. has raised $14 million in seed funding to accelerate its… Read More

7 hours ago

Bristol Myers Squibb & Bain Capital Launch a Bold New Biotech Venture to Tackle Autoimmune Diseases

Reimagining Immunology, Together In a groundbreaking partnership, Bristol Myers Squibb (BMS) and Bain Capital have come together to launch a… Read More

7 hours ago

Genethon Launches Promising New Trial in Europe for Duchenne Muscular Dystrophy Big Step Forward for Gene Therapy

Genethon, a global leader in gene therapy for rare genetic diseases, has received the green light from the UK and… Read More

7 hours ago